CB
HZNP

Commerce Bank’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Commerce Bank’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,766
Closed -$551K – 1213
2023
Q3 		$551K Buy
4,766
+35
+0.7% +$3.76K ﹤0.01% 761
2023
Q2 		$487K Buy
4,731
+2,409
+104% +$254K ﹤0.01% 814
2023
Q1 		$253K Sell
2,322
-1,566
-40% -$173K ﹤0.01% 1041
2022
Q4 		$442K Sell
3,888
-1,094
-22% -$90.9K ﹤0.01% 840
2022
Q3 		$308K Buy
4,982
+239
+5% +$16.7K ﹤0.01% 944
2022
Q2 		$378K Buy
4,743
+256
+6% +$24.2K ﹤0.01% 871
2022
Q1 		$472K Sell
4,487
-1,960
-30% -$191K ﹤0.01% 854
2021
Q4 		$694K Buy
6,447
+9
+0.1% +$982 ﹤0.01% 735
2021
Q3 		$705K Buy
6,438
+3,589
+126% +$373K 0.01% 716
2021
Q2 		$267K Buy
2,849
+90
+3% +$8.28K ﹤0.01% 1046
2021
Q1 		$254K Buy
+2,759
New +$233K ﹤0.01% 1031

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Commerce Bank's HZNP Position: Q4 2023 in Review

Commerce Bank sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 4,766 shares — an estimated $551K sold.

Commerce Bank first reported a position in HZNP in Q1 2021 and held it in 11 quarters. The position peaked at $705K in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Commerce Bank reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Commerce Bank sold 4,766 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $551K.
  • Commerce Bank first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 11 quarters.
  • Commerce Bank's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $705K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Commerce Bank's 13F filing for Q4 2023, filed 9 Feb 2024.